Evidence map›Paper›PMID 40321680›Full record

ArticleCanadian journal of kidney health and disease2025

Nephrologist's Perceptions of Risk of Severe Chronic Kidney Disease and Outpatient Follow-up After Hospitalization With AKI: Multinational Randomized Survey Study.

Dilaram Acharya, Tayler D Scory, Nusrat Shommu, Maoliosa Donald, Tyrone G Harrison, Jonathan S Murray, Simon Sawhney, Edward D Siew, Neesh Pannu, Matthew T James

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dilaram AcharyaDepartment of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.
Tayler D ScoryDepartment of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.
Nusrat ShommuDepartment of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.
Maoliosa DonaldDepartment of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.
Tyrone G HarrisonDepartment of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0003-1068-8673
Jonathan S MurraySouth Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.ORCID https://orcid.org/0000-0002-5979-4664
Simon SawhneyAberdeen Centre for Health Data Science, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, UK.
Edward D SiewDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN, USA.
Neesh PannuDepartment of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0002-8626-8504
Matthew T JamesDepartment of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0002-1876-3917

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients hospitalized with acute kidney injury (AKI) have variable risks for chronic kidney disease (CKD); however, there is limited knowledge about how this risk influences outpatient follow-up with nephrologists. Objective: This survey study examined the likelihood that nephrologists would recommend outpatient follow-up of patients with varying risk profiles for CKD after hospitalization with AKI and the effect of reporting the predicted risk of severe CKD on their decision-making. Design: A randomized survey study examining the impact of providing predicted risks of severe CKD on nephrologists' follow-up recommendations for patients with AKI. Setting: The study included nephrologists from the United States, the United Kingdom, and Canada between September and December 2023. Patients: Participants reviewed clinical vignettes of patients with AKI and varying risks of severe CKD (G4 or G5), using an externally validated prediction model. Measurements: The primary outcome was the likelihood of recommending nephrologist specialist follow-up for each case, scored on a 7-point Likert scale (1 = "definitely not" and 7 = "definitely would"). Methods: Participants were randomized to receive a version of the survey either with or without the predicted risk of severe CKD included for each vignette. Responses were compared across categories of predicted risk (<10%, 10%-49%, and ≥50%) using generalized estimating equations. Results: Of the 203 nephrologists who participated, 73 (36%) were from the United Kingdom, 71 (35%) from Canada, and 45 (22%) from the United States. Mean (95% confidence interval [CI]) Likert scores increased from 4.01 (3.68, 4.34) for patients with a <10% predicted risk to 6.06 (5.76, 6.37) for those with a ≥ 50% predicted risk of severe CKD. Nephrologists were significantly less likely to recommend outpatient nephrology follow-up for patients with a <10% predicted risk of severe CKD when the risk was reported (mean difference = -0.71 [95% CI = -1.19, -0.23]), and significantly more likely to recommend follow-up for patients with a ≥50% predicted risk when the risk of severe CKD was reported (mean difference = 0.49 [95% CI = 0.04, 0.93]). Limitations: This study focuses on nephrologists from high-income countries and relies on hypothetical scenarios rather than real-world practices. Survey respondents may not be representative of all nephrologists, although consistent findings across diverse subgroups strengthen findings. Conclusions: When the predicted risk of severe CKD is reported, nephrologists are less likely to recommend follow-up for lower risk patients with AKI and more likely to recommend follow-up for higher risk patients, leading to better alignment of recommendations for outpatient follow-up with patient risk of severe CKD.

Indexed as

acute kidney diseasechronic kidney diseasekidney healthnephrologist follow-uprisk stratification

Identifiers

PMID40321680
PMCPMC12046161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.